Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
POSTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DCAF15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF408 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-DPB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MIR6791 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C4B_2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF581 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM262 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPHK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBOAT7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC339988 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RANBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on